Clinical trial for Coronary Artery Disease
Official title Use of Shock Wave Therapy for Neo-Vascularisation in Non-critical Coronary Artery Disease: Validation by Quantitative Cardiac MRI Perfusion
ClinicalTrials.gov ID: NCT07068399
What this study is testing
- What it's testing
- This is a controlled trial aimed to demonstrate the effect of cardiac extracorporeal shock wave therapy (CSWT) on the angiogenesis effect of myocardium by determining myocardial perfusion and left ventricular function in patients with coronary artery disease (CAD) when measured by cardiac MRI before and after the treatment.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Patients with symptoms of coronary artery disease
- Patients without obstructive coronary artery disease
- with LVEF not \< 40%.
You likely can't join if
- Age \< 18 years,
- Pregnancy or lactation.
- Contraindication to contrast enhanced stress Cardiac Magnetic Resonance (eg.
- Life expectancy \<24 months
- Haemodynamically unstable
- Participation in other clinical trial within 6 months of enrollment.
See the full eligibility criteria
- Patients with symptoms of coronary artery disease
- Patients without obstructive coronary artery disease
- with LVEF not \< 40%.
- Age \< 18 years,
- Pregnancy or lactation.
- Contraindication to contrast enhanced stress Cardiac Magnetic Resonance (eg. Estimated GFR \<30ml/min/1.73m2, severe allergy to gadolinium based contrast agent, contraindication to adenosine)
- Life expectancy \<24 months
- Haemodynamically unstable
- Participation in other clinical trial within 6 months of enrollment.
- Recent myocardial infarction within 6 months.
- Unable to consent to or perform components of the study.
The study team makes the final eligibility decision.
Where it is enrolling
- Hong Kong, Hong Kong
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Hong Kong, Hong Kong. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.